Skin Disorders News

BOSTON — Rheumatologists, gastroenterologists, dermatologists, immunologists and other health care providers who care for patients with immune-mediated inflammatory diseases will gather at the Interdisciplinary Autoimmune Summit in Boston this weekend for a collaborative discussion of treatment strategies.

Many rheumatic diseases – including systemic lupus erythematous, scleroderma and the various forms of psoriasis – present with a multitude of dermatologic symptoms that clinicians can easily confuse with other conditions.

Patients who have other allergic diseases are more likely to develop eosinophilic esophagitis, according to research presented at the 2018 American Academy of Allergy, Asthma & Immunology and World Allergy Organization Joint Congress.

In the United States, ED visits for eczema are common, seem to be rising and contribute to a substantial cost-burden, according to findings presented at the American Academy of Dermatology Annual Meeting.

BOSTON — A C1-esterase inhibitor (human) delivered subcutaneously for the treatment of long-term prophylaxis associated with hereditary angioedema decreased attacks by 90% compared with therapy administered intravenously, according to findings presented at the ACAAI Annual Scientific Meeting.

BOSTON — The landscape of hereditary angioedema and how it is diagnosed, assessed and treated has been ever-evolving and will continue to change as new treatment options for the rare disorder are identified, according to Michael E. Manning, MD, FAACI, of Allergy, Asthma & Immunology Associates LTD in Arizona.

BOSTON — Although total immunoglobulin E levels were unrelated to severity of hospital stay, children experience increasingly intense hospital courses if they have a family history of asthma or prior pediatric eczema, according to a recent presentation at the American College of Allergy, Asthma and Immunology’s Annual Scientific Meeting.

Healio.com/Allergy will present live coverage of the 75th American Academy of Allergy, Asthma and Immunology annual meeting from Boston beginning Oct. 26 through Oct. 30.

Adult patients with moderate to severe atopic dermatitis demonstrated improvements in overall disease severity after treatment with Dupixent, according to findings from the CAFÉ trial presented at the European Academy of Dermatology and Venereology Congress.

The use of Lactobacillus rhamnosus GG, a probiotic, is unable to prevent asthma or eczema in children at 2 years of age when used in the first 6 months of life.